Introduction
Replicative senescence is believed to represent a tumor suppression mechanism that the aspiring tumor cell must overcome in order to achieve an immortal state. Growth beyond the replicative senescence checkpoint (Hay¯ick limit) correlates well with genetic lesions that interfere with one or more key cellular mortality pathways, most prominently Myc, Rb and/or p53 Wright and Shay, 1995) . Studies addressing the relationship between telomere length, telomerase regulation and replicative capacity have established a critical role for the telomerase catalytic protein component or TERT (for Telomerase Reverse Transcriptase) (Bodnar et al., 1998; Vaziri and Benchimol, 1998; Nakamura et al., 1997; Meyerson et al., 1997; Harrington et al., 1997; Kilian et al., 1997; Nakayama et al., 1998) in immortalization. Speci®cally, normal human somatic cells can acquire the ability to maintain telomeres and replicate well beyond the Hay¯ick limit by stable enforced expression of TERT (Bodnar et al., 1998; Vaziri and Benchimol, 1998) . However, in certain primary cell types TERT can only bypass senescence in the presence of a cooperating event such as loss of Rb function (Kiyono et al., 1998) . The ability of TERT to extend cellular replicative potential, not only illustrates the requirement of telomere maintenance for continued cellular growth, but also raises the possibility that the genetic elements governing TERT gene expression may be important targets in the oncogenic process.
The dysregulation of TERT gene expression may play an important role in facilitating tumor development. This notion is supported by the observation that TERT transcripts are low or undetectable in most human primary somatic cells and tissues, but readily observable in the same cell or tissue type following neoplastic transformation (Nakamura et al., 1997; Meyerson et al., 1997) . Moreover, in approximately 90% of all tumors, telomerase activity (Kim et al., 1994) as well as TERT expression (Nakamura et al., 1997; Meyerson et al., 1997; Harrington et al., 1997; Kilian et al., 1997; Nakayama et al., 1998) are detected. Together, these ®ndings are consistent with the hypothesis that either activation of oncogene or loss of tumor suppressor function serves to override the strict repression of TERT in primary somatic cells. This hypothesis is supported by the ability of oncogenic variants of the Human Papiloma Virus (HPV) E6 protein to induce strong telomerase activity in primary human keratinocytes and mammary epithelial cells, while weakly oncogenic variants induce signi®cantly less telomerase activity (Klingelhutz et al., 1996) . Conversely, introduction of pRB into tumor cell lines has been shown to repress telomerase activity (Xu et al., 1997) . In addition, exposure of three dierent human leukemic cell lines to antisense c-myc oligonucleotides results in down-regulation of telomerase activity (Fujimoto and Takahashi, 1997) ; whereas Nmyc gene ampli®cation in neuroblastoma is associated with high telomerase activity (Hiyama et al., 1995) . These observations, together with highly similar expression pro®les for mTERT and c-myc during mouse erythroleukemia (MEL) cell dierentiation and mitogen-stimulated lymphocyte proliferation (Greenberg et al., 1998; Lachman and Skoultchi, 1984; Reed et al., 1986) , imply a potential link between increased Myc transactivation activity and up-regulation of TERT gene expression in normal proliferating and transformed cells. Indeed, recent evidence has shown that enforced expression of c-Myc in normal human ®broblasts or normal human mammary epithelial cells leads to increased expression of hTERT (Wang et al., 1998) . However, to date it remains unclear as to whether c-Myc acts directly to upregulate transcription of the hTERT gene and whether this TERT gene activation by Myc represents a critical functional aspect of Myc immortalization activity.
c-Myc has been demonstrated to enhance transcription of a number of direct target genes including aprothymosin , ornithine decarboxylase (Bello-Fernandez et al., 1993; Wagner et al., 1993) , cdc25A (Galaktionov et al., 1996) , and MrDb (Grandori et al., 1996) . In addition, c-Myc has been demonstrated to repress transcription of the growth arrest genes gas1 (Lee et al., 1997) and gadd45 (Marhin et al., 1997) . Identi®cation of Myc targets which both positively and negatively regulate cell growth may explain the prominent and essential role of Myc in control of cell growth. The ability of c-Myc to immortalize primary cells suggests that Myc likely regulates expression of genes that facilitate passage through replicative senescence. Expression of hTERT in BJ ®broblasts or retinal pigment epithelial cells is known to extend lifespan of these cells beyond the Hay¯ick limit (Bodnar et al., 1998) . Similarly, expression of c-Myc in IMR90 ®broblasts and human mammary epithelial cells extends the lifespan of these cells with a concomitant increase in telomerase activity (Wang et al., 1998) . Therefore, the ability of Myc to stimulate expression of hTERT directly could account in part for the immortalizing function of Myc and the concomitant increases in hTERT expression.
In this study, we identi®ed the hTERT gene as a direct target for transcriptional regulation by c-Myc. Expression of c-Myc and hTERT were coordinately regulated during the dierentiation of mouse erythroleukemia cells. Furthermore, a hormone inducible cMyc Estrogen Receptor (c-Myc-ER) fusion protein (Eilers et al., 1989; Littlewood et al., 1995 ) was used to demonstrate that c-Myc can potently upregulate telomerase activity and TERT gene expression in a primary human ®broblast cell line, IMR90. Activation of c-Myc-ER led to rapid upregulation of hTERT expression in the absence of de novo protein synthesis. Moreover, the activity of the hTERT promoter was dramatically enhanced by c-Myc-ER in NIH3T3 cells. Strikingly, the ability of c-Myc-ER to enhance hTERT promoter activity was dependent upon sequences in the hTERT promoter which included an evolutionarily conserved Myc binding site (E-box). The capacity of Myc to regulate TERT expression suggests one mechanism by which c-Myc may execute its immortalizing potential. However, the inability of TERT to substitute for Myc in the rat embryo ®broblast (REF) cooperation assay, suggests that the oncogenic actions of Myc are more complex and extend beyond its ability to upregulate the limiting component of the telomerase enzyme.
Results

Coordinate regulation of c-Myc and TERT gene expression
Upon hexamethylene bisacetamide (HMBA) induction of MEL cell dierentiation, c-Myc and TERT exhibit highly regulated and strikingly similar patterns of gene expression (Lachman and Skoultchi, 1984; Greenberg et al., 1998) . To examine more closely the relationship between c-Myc and TERT gene expression, we measured steady state c-myc and TERT mRNA levels following HMBA treatment in parental MEL cultures and in Myc56MEL cells, a well characterized MEL clonal derivative that constitutively expresses c-Myc (Dmitrovsky et al., 1986) . As shown in Figure 1 , HMBA-exposure of parental MEL cultures was associated with a rapid 3 ± 4-fold decline in both cmyc and TERT mRNA levels by 4 h post-induction as reported previously (Greenberg et al., 1998) . In contrast, c-myc and TERT expression in the HMBAtreated Myc56MEL cultures remained at pre-induction levels in two separate experiments. The coordinate regulation of c-Myc and TERT gene expression in this cell culture-based dierentiation system was consistent with the notion that c-Myc, rather than HMBA treatment per se, regulates TERT gene expression.
c-Myc enhances telomerase activity IMR90 cultures do not possess detectable telomerase activity or TERT gene expression (Nakamura et al., 1997; Meyerson et al., 1997) . To determine whether experimental induction of c-Myc can lead to the de novo activation of telomerase in primary human cells, pre-senescent IMR90 cultures engineered to express the mouse ecotropic receptor were transduced with either the pBABE retroviral vector or one encoding the cMyc-Estrogen Receptor (MycER) fusion protein. In the MycER system, the Myc moiety exists in a latent form bound in a complex with HSP-90 through its ER fusion (Eilers et al., 1989; Littlewood et al., 1995) . Upon treatment with 4-hydroxy-tamoxifen (4-OHT), the MycER protein is liberated from HSP-90, resulting in a Myc over-expression phenotype (Eilers et al., 1989; Littlewood et al., 1995) .
Employing this cell culture system, 4-OHT treatment of MycER-transduced IMR90 cultures resulted in the marked and sustained activation of telomerase to a level at or above that detected in lysates derived from an equivalent number of telomerase-positive 293T tumor cells as assayed by the sensitive TRAP assay ( Notably, enforced expression of oncogenes such as H-Ras, and cellular modulators of the Rb and p53 pathways (E7, cyclin D1, Mdm2, dominant-negative p53) were not capable of in¯uencing telomerase activity in IMR90 cells (Wang et al., 1998 and our data not shown). These observations suggested that Myc may play a prominent and direct role in the regulation of hTERT gene expression.
Conservation of human and mouse TERT promoters
To determine whether the ability of c-Myc to enhance telomerase activity was mediated through increased transcription of the hTERT gene we compared the human and mouse TERT promoters. Alignment of the ®rst 300 bases of the human and mouse promoters indicates a number of conserved regions (Figure 3a) . In particular, the Myc/Max binding site (E-box) located at 734 of human promoter and at 732 of the mouse promoter, are highly conserved with respect to the core nucleotides which comprise the E-box, nucleotides
anking the E-box and position of the E-box relative to the translation start site. A second E-box was identi®ed at 7242 of the human promoter; however, this site was not conserved in the mouse promoter. These observations raised the possibility that the conserved Myc binding site in particular might play a role in regulation of hTERT expression by c-Myc. It is possible that the hTERT promoter possesses other cis regulatory elements critical to the regulation of TERT gene. There are two SP1 binding sites, located at 7168 and 7134 (Figure 3a) , which are highly conserved between the mouse and human promoters suggesting that SP1 may play a role in the regulation of TERT expression. Further analysis of the human and mouse promoter sequences indicated other regions of sequence conservation including the region between 71106 and 71602 of the human promoter which is highly conserved with the region between 7916 and 71340 of the mouse promoter (Figure 3b) . Binding sites for a number of transcription factors, including the sex determining region Y gene product (SRY), hepatic nuclear factors 3beta (HNF-3b) and 5 (HNF-5), TFIID-MBP, E2F and c-Myb are found within this region of both the mouse and human promoters. Although conserved, the functional relevance of these putative cis elements remains to be determined.
c-Myc enhances hTERT promoter activity
To determine whether the increased telomerase activity induced by activation of c-Myc-ER was a result of increased transcription of the hTERT gene we initially examined the eect of 4-OHT induction of c-Myc-ER activity upon hTERT promoter sequences placed upstream of the secreted alkaline phosphatase reporter gene. The hTERT promoter contains two putative Figure 2 Expression of telomerase activity following induction of c-Myc-ER. IMR90 ®broblasts transduced with either pBABE vector control or MycER were cultured in media containing 1 mM 4-OHT for the indicated times and then cells were harvested for TRAP telomerase assays. TRAP assays were performed on lysates equivalent to 1000 cells for all samples, with 293T cell lysates serving as a positive control for telomerase activity. PCR internal controls from each experiment were ampli®ed equally (data not shown). HI=inactivation of lysate for 5 min at 858C prior to the TRAP assay Myc-binding sites positioned at 7242 and 734 relative to the ATG initiation codon. The proximal Mycbinding site is conserved between the human and mouse promoters. Therefore, NIH3T3 cells engineered to express c-Myc-ER stably were transfected with constructs containing a secreted alkaline phosphatase reporter under the control of a 2.5 kb fragment of the hTERT promoter, a 2.5 kb fragment of the hTERT promoter lacking the proximal E-box, or a promoterless reporter construct (see Figures 3a and 4a) . The basal activity of the wild-type hTERT promoter and that of the hTERT promoter lacking the proximal Ebox were equivalent and approximately threefold higher than the activity of the promoterless reporter (Figure 4) . Induction of c-Myc-ER activity with 1 mM 4-OHT enhanced the activity of the 2.5 kb hTERT promoter approximately tenfold (Figure 4) . By contrast, the activity of the promoter lacking the (71106 to 71612) and mouse (7916 to 71340) TERT promoter sequences. Alignments were performed and identity calculated as described in Experimental procedures. Cis-elements common to both promoters are indicated by shaded regions proximal E-box was not signi®cantly aected by induction of c-Myc-ER. Similarly, the promoterless reporter was not aected by induction of c-Myc-ER. These results suggest that the ability of c-Myc to stimulate the hTERT promoter is mediated via the 734 E-box.
hTERT is a direct target of c-Myc regulated transcription
To con®rm the ability of c-Myc to stimulate transcription of the hTERT gene directly, we assayed for hTERT gene expression in MycER-transduced cultures of IMR90 cells 0, 1, 3 and 9 h following the addition of 4-OHT. The cultures were treated with cyclohexamide for 30 min prior to addition of 4-OHT to prevent de novo protein synthesis. hTERT expression was undetectable at the zero hour time point for the Myc transduced cultures ( Figure 5, lane 1) . Pretreatment of these cells with cyclohexamide alone had no eect on expression of hTERT mRNA ( Figure  5 , compare lane 1 with lanes 2 and 6). Induction of the c-Myc-ER activity by treatment with 2 mM 4-OHT in the presence of 1 mM cyclohexamide led to a rapid increase in expression of hTERT message. hTERT expression was detected by 1 h post-induction ( Figure  5 , compare lanes 6 and 7), and increased 3 and 9 h post induction. By contrast, cells treated with solvent alone were not induced to express hTERT ( Figure 5 , compare lane 2 with lanes 3, 4 and 5). Furthermore, the expression level of GAPDH was similar at all time points in cells treated with 4-OHT or solvent alone. These observations strongly suggest that Myc acts directly upon the hTERT promoter to enhance transcription of the hTERT gene.
Lack of equivalence of Myc and TERT in cellular transformation
To further explore the functional implications of Myc induction of telomerase activity in primary cells, we examined whether TERT could substitute for c-Myc as an immortalizing agent in the rat embryonic ®broblast (REF) cooperation assay. In this assay, co-transfection of Myc and activated RAS (H-RAS G12V ) eects the malignant transformation of early passage REFs. This cooperative activity can be quanti®ed by monitoring the number of transformed foci appearing in the monolayer 7 ± 10 days post-transfection. In two separate experiments, various combinations of the expression constructs encoding c-myc, H-RAS G12V , TERT, or vector control were introduced into early passage REFs. Strong cooperative activity was observed in the RAS and Myc co-transfections as evidenced by an average of 34 foci per 10 cm plate ( Figure 6 , Myc+RAS); while Ras alone generated between 0 and 3 foci per plate (Figure 6 , RAS+pBABE), consistent with previous ®ndings that an immortalizing agent and activated RAS are required for ecient transformation of primary rodent cells (Land et al., 1983) . By contrast, co-transfection of TERT and RAS did not generate transformed foci counts above that scored for the RAS alone controls. These results indicate that expression of hTERT is Figure 4 c-Myc-ER acts through an evolutionarily conserved Ebox to stimulate the hTERT promoter. (a) Schematic illustration of the structure of the hTERT-SEAP reporters. E2 and E1 represent the distal and evolutionarily conserved proximal Eboxes, respectively. The promoterless reporter is pSEAP-Basic (Clontech). (b) Eect of c-Myc-ER on the activity of the hTERT promoter in NIH3T3 cells was determined by detection of secreted alkaline phosphatase activity. Cells were treated with 4-OHT for 36 h; Uninduced cells were treated with solvent alone for 36 h. The detected secreted alkaline phosphatase activity was corrected for transfection eciency in each case using bgalactosidase. Results shown are the average of three independent experiments plus and minus the standard deviation of the mean Figure 5 hTERT expression is enhanced by induction of c-Myc-ER activity in the absence of de novo protein synthesis. Expression of endogenous hTERT following exposure to 4-OHT (or solvent alone) for the indicated times in the presence of 1 mM cyclohexamide in IMR90 ®broblasts transduced with MycER. Reverse transcription of RNA derived from each sample followed by PCR and Southern blotting of the ampli®ed products was carried out as previously described in the Experimental procedures section. Glyceraldehyde-6-phosphatase dehydrogenase (GAPDH) was ampli®ed from the same reverse transcription products as an internal semi-quantitative control and visualized by ethidium bromide staining. Low level expression of hTERT mRNA was detected in uninduced samples after very long exposures; however, the level of hTERT mRNA did not change over time in the uninduced samples. 
Discussion
Telomere attrition in the absence of telomerase has been shown to be an intrinsic timing mechanism that controls the number of somatic cell divisions prior to senescence (Harley et al., 1990; Hastie et al., 1990; Counter et al., 1992; Bodnar et al., 1998) . The prominence of TERT in telomere homeostasis and the pro®le of TERT gene expression in normal and neoplastic settings prompted us to determine whether various cellular growth control and transcriptional factors regulate TERT gene expression and/or telomerase activity in primary human lung ®broblasts. Recent evidence indicates that expression of TERT and telomerase activity can be induced by the E6 oncoprotein or by c-Myc (Wang et al., 1998) . Other oncogenes (e.g. H-Ras), or regulators of the Rb (e.g. cyclin D1 and E2F-1) or p53 (e.g. Mdm2) pathways are not capable of inducing telomerase activity (Wang et al., 1998 and our data not shown), suggesting that cMyc may play a critical role in regulation of TERT expression and hence telomerase activity. Here, we observe that c-Myc acts as a potent activator of telomerase activity through the rapid upregulation of TERT gene expression. hTERT meets all the criteria of a bona ®de Myc target gene as de®ned for other Mycresponsive genes involved in diverse cellular processes such as DNA synthesis and cell cycle control, among others (Grandori and Eisenman, 1997) . The level and kinetics of hTERT mRNA expression during differentiation of mouse erythroleukemia cells is identical to that of c-Myc. In addition, c-Myc enhances the activity of the hTERT promoter, an eect that is completely abrogated by deletion of a single Myc/Max binding site within the core promoter. Furthermore, the ability of c-Myc-ER to enhance expression of hTERT is resistant to inhibition of protein synthesis.
The identi®cation of hTERT as a Myc target is intriguing given Myc's classi®cation as an immortalizing oncogene. On the surface, the ability of Myc overexpression to sustain telomerase activity suggests a basis for the extended growth beyond the Hay¯ick limit, possibly through maintenance of telomere repeats. Expression of c-Myc does result in telomere maintenance in human mammary epithelial cells (Wang et al., 1998) . However, expression of c-Myc in IMR90 cells does not appear to lead to maintenance of telomere length although these cells do exhibit extended lifespan (Wang et al., 1998 and data not shown) suggesting that overexpression of Myc can override senescence signals coincident with critical telomere attrition. The previously observed inability of c-Myc induced hTERT expression to sustain telomere length (Wang et al., 1998) may be due to other factors which regulate telomerase activity. For example, TRF1 may limit accessibility of telomerase to the telomere despite enhanced expression of hTERT (van Steensel and de Lange, 1998) . The inhibitory function of TRF1 could be relieved by overexpression of the recently described ADP-ribosylase Tankyrase (Smith et al., 1998) , and it is tempting to speculate that this eect may be independent of c-Myc.
The inability of TERT overexpression to substitute for Myc in the REF cooperation assay, in conjunction with the previous observation that c-Myc can bypass replicative senesence despite substantial telomere loss (Wang et al., 1998) , suggests that the oncogenic actions of c-Myc extend beyond the activation of TERT gene expression and telomerase activity. The ability of cMyc to regulate expression of other genes involved in the senescence checkpoint may account for the ability of c-Myc to extend the lifespan of normal cells. Nevertheless, since maintenance of telomere length appears to be essential for ecient tumorigenesis in vivo (Greenberg and DePinho, unpublished) , it is likely that the ability of c-Myc to stimulate expression of hTERT and thereby enhance telomerase activity represents an important, albeit insucient, aspect of c-Myc-directed immortalization and transformation.
Materials and methods
Retroviral infection
The mouse ecotropic receptor (gift from Scott Lowe; (Serrano et al., 1997) ) was transduced into IMR90 ®broblasts and all subsequent transductions with ecotropic retrovirus were carried out according to Serrano et al. (1997) . pBABE-MycER and pBABE vector control viruses were harvested from stable expressing C2 cell lines. Lachman and Skoultchi (1984) . The MEL cell line, Myc56, constitutively expressing human c-myc was a generous gift of Arthur Skoultchi (Dmitrovsky et al., 1986) .
Telomerase assays
Telomerase activity was measured by a modi®ed telomerase repeat ampli®cation protocol using the TRAPeze telomerase detection kit (Oncor, Gaithersburg, MD, USA) (Kim et al., 1994) . All reactions were performed on lysates equivalent to 1000 cells. Genomic DNA was obtained from vector control or MycER transduced IMR90 ®broblasts.
Cloning and anlaysis of human and mouse TERT promoters hTERT Phage pools of a human W138 lung ®broblast genomic library (Stratagene) were screened by PCR using primers to the 5' end of the hTERT cDNA (pGRN121) to identify a recombinant phage (lGf5) which contained a 15 kb insert encompassing the hTERT initiating methionine. A NotI fragment containing the lGf5 insert was subcloned into pGRN1185 (a pBluescript II SK+ derivative) to generate pGRN142. Sequencing of pGRN142 showed it contained 13.5 kb of DNA upstream of the hTERT open reading frame (Accession number F121948).
mTERT A hybridization probe (nucleotides 1586 ± 1970) of the mTERT cDNA (pGRN188) was used to identify a recombinant phage (lmTERT1) from a 129SV mouse genomic phage library (Stratagene). An 8 kb HindIII fragment of lmTERT1 that hybridized to the 1586 ± 1970 probe was subcloned into pBluescript II KS+ (Stratagene) to generate clone B2.18 (pGRN233). The regions encompassing the initiator and promoter were sequenced (Accession number F121949).
The human and mouse promoter sequences were aligned using the GAP program from the Wisconsin GCG package using a value of 48 for gap creation and a value of 3 for gap extension. Using a small portion of the coding region (*450 bases) was found to improve the initial alignment.
hTERT reporter construction
To construct pGRN150 (DE-box reporter) the BglII-FspI fragment from pGRN144, a subclone of lGf5, containing 2.5 kbp of the hTERT promoter region, was inserted into the BglII and NruI sites of pSEAP2-Basic (Clontech). The pGRN261 (2.5 kbp hTERT reporter) was constructed by in vitro mutagenesis of pGRN144 using the oligonucleotide RA94 (5'-CCCGGCCACCCCCGCGAATTCGCGCGCTC-CCCGCTGC-3', altered bases are indicated in bold) to introduce an EcoRI site instead of the initiating methionine of the hTERT open reading frame. The BglII ± EcoRI fragment from the mutagenized plasmid containing 2.5 kbp of the hTERT promoter region was then inserted into the BglII and EcoRI sites of pSEAP2-Basic.
Reporter assays NIH3T3 cells were transfected using LipoFectamine reagent (Life Sciences) with 100 ng of the indicated promoter reporter, and 200 ng of pCMX-b-Galactosidase which served as an internal control for transfection eciency. Transfected cells were allowed to recover for 6 h in complete DMEM and then treated with 1 mM 4-OHT or ethanol for 36 h prior to analysis of secreted alkaline phosphatase activity using the Great EscAPe assay (Clontech). bgalactosidase activity was assayed by incubation of whole cell extracts with 400 mg/ml ONPG in buer containing 60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 10 mM KCl and 1 mM MgSO 4 and relative transfection eciencies determined by reading absorbance at 415 nm.
Expression studies
Reverse transcription of 1 mg total RNA derived from the indicated IMR90 cultures, was performed with the Superscript RT kit (Stratagene) using an oligo-dT primer according to the manufacturers speci®cations in 20 mL total volume. PCR was performed on 2 mL of the reverse transcriptase reaction with primers HT1553F and HT1893R (Kilian et al., 1997) for 35 cycles of 948C for 45 s, 608C for 45 s, and 728C for 90 s. PCR products were run on a 1.5% agarose TBE gel and transferred to nitrocellulose. Blots were probed with a random-primed 32 P-labeled hTERT fragment (nucleotides 1680 ± 2700) in hybridization solution containing 50% formamide at 428C for 6 h. Blots were exposed to Biomax MS ®lm (Kodak) for 3 h. GAPDH controls were coampli®ed with primers K136 and K137 as previously described (Nakamura et al., 1997) , run on 1.4% agarose TBE gels and visualized by ethidium bromide staining.
Rat embryo ®broblast cooperation assay
REFs were transfected with expression constructs of c-myc, H-RAS
G12v
, mTERT, and pBABE vector control according to Figure 5 , by the calcium phosphate method as described (Schreiber-Agus et al., 1995) . Plates were split 1 to 3 at 20 h after transfection and media was changed every 3 days. Foci were counted 8 days after transfection and stained with crystal violet for photographic illustration.
Note added in proof Mutation of the evolutionarily conserved E-box at position 734 from CACGTG to CACTCA prevented activation of the hTERT promoter by c-Myc-ER (data not shown). This observation con®rms that it is this E-box that mediates Myc activation of the hTERT promoter, and not thē anking sequences or the E-box at 7242.
